The Dallas Stars are bringing back a pair of restricted free agent forwards. The team has announced a five-year, 16.25MM extension with Radek FaksaThey have also revealed a new two-year, two-way contract with Joel L’Esperanceexpected to be worth his qualifying offer of $725K at the NHL level.

There was some skepticism that Faksa would receive a long-term deal and significant raise this off-season, but that is exactly what he got. Playing on a $2.2MM AAV for the past three years, Faksa has failed to surpass his point total from the year prior to signing his previous extension. The 2019-20 campaign was especially disappointing, as Faksa recorded just 20 points after totaling 30 points or more in each of his three full NHL seasons. The two-way center also saw his defensive effectiveness slip this past season. Yet, none of this seems to matter. Faksa is still a useful player and Dallas was happy to keep him around, no matter the cost. Faksa is locked in to five more years with Dallas and will count for more than $1MM more against the cap with his new $3.25MM AAV.

While he’s a helpful two-way presence, handing Faksa a raise that his statistics don’t necessarily back up could come back to bite the Stars. The team still needs to re-sign RFA forwards Denis Gurianov and Roope Hintzboth of whom absolutely proved that they are top-six players deserving of significant contracts. However, they only have about $6.66MM in cap space remaining and Gurianov and Hintz alone would not fill out the roster. The Stars likely needed to get creative with the cap this off-season anyhow, but the pressure is now on to figure out their roster – before Gurianov or Hintz receive an offer sheet.

L’Esperance could be an affordable option to take on a roster spot for the cap-strapped club. The young center has played in 21 games with Dallas over the past two seasons and has been a productive player for AHL Texas. While he has yet to make much of an offensive impact in the NHL, experience and affordability could lead to opportunity for L’Esperance.

View Comments (3)